A COVID Vaccine for All

Trouble viewing? View in your browser. View all Scientific American publications.

    

January 04, 2022

Vaccines A COVID Vaccine for All With proved technology and no-frills tech transfer, CORBEVAX is poised to reach hundreds of millions in the coming weeks By Peter J. Hotez,Maria Elena Bottazzi

Creativity Salvador Dali's Creative Secret Is Backed by Science The painter described falling into the briefest of slumbers to refresh his mind. Now scientists have shown the method is effective at inducing creativity. By Christopher Intagliata | 03:43

Geology New Technology Monitors Collapsing Glaciers Deep vibrations called infrasound can provide an early warning of ice avalanches' speed and trajectory By Ellis Avallone

Astrophysics Hollywood Can Take On Science Denial: Don't Look Up Is a Great Example This new release uses a comet hurtling toward Earth to satirize the way we dismiss scientific facts and the scientists who discover them By Rebecca Oppenheimer

Culture Sometimes Science Is Wrong Research is a self-correcting process, but that fact is often lost on the public By Michael D. Lemonick

Sexuality People Have Been Having Less Sex--whether They're Teenagers or 40-Somethings Among the young, social media, gaming and "rough sex" may contribute to this trend By Emily Willingham

Cancer A $1-Billion Boost to the NCI Will Help Us Beat Cancer The organization's underfunding means critical research is not being done By Senator Chris Coons,Senator Jerry Moran

Climate Change The Five Biggest Climate Stories of 2021 Climate-fueled disasters raged around the globe while international action fell short of ambitions By Andrea Thompson

Behavior We Learned the Wrong Lessons from the Tuskegee 'Experiment' It's understandable that Black Americans are wary of vaccines, but that despicable episode involved the withholding of treatment, whereas vaccines actively prevent disease By Melba Newsome

Behavior Racism in Health Care Isn't Always Obvious As physicians, we believe that recognizing it begins with understanding our own privilege and biases By Joseph V. Sakran,Ebony Jade Hilton,Chethan Sathya

Public Health After Surgery, Black Children Are More Likely to Die Than White Children A study of nearly 200 U.S. medical centers found that even apparently healthy kids suffer racial disparities in complications associated with surgery By Jim Daley

Ethics Will Giving COVID Booster Shots Make It Harder to Vaccinate the Rest of the World? Wealthy countries have bought up most of the available vaccine doses for booster shots but still have far more than they need By Sara Reardon

FROM THE STORE Scientific American Mind, Volume 33, Issue 1

ADVERTISEMENT

FROM THE ARCHIVE COVID, Quickly, Episode 1: Vaccines, Variants and Diabetes Today we begin a new podcast series: COVID, Quickly. Every two weeks, Scientific American's senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between. By Tanya Lewis,Josh Fischman,Jeffery DelViscio,Sunya Bhutta | February 2021

QUOTE OF THE DAY "Two years into the pandemic, CORBEVAX is the first COVID vaccine designed specifically for global health. It is a milestone for global vaccine equity, something we believe will overcome vaccine hesitancy, and serves as a blueprint for how to develop a potent vaccine for pandemic use in the absence of substantial public funding." Peter J. Hotez and Maria Elena Bottazzi, Baylor College of Medicine, Scientific American

LATEST ISSUES

Questions?   Comments?

Download the Scientific American App

To view this email as a web page, go here. You received this email because you opted-in to receive email from Scientific American. To ensure delivery please add news@email.scientificamerican.com to your address book. Unsubscribe     Manage Email Preferences     Privacy Policy     Contact Us